Back to results
US 2024/0002923 A1Published application
Methods and kits for determining the efficiency of plasma separation from whole blood
AssigneeNucleix Ltd.
InventorsDanny FRUMKIN, Adam WASSERSTROM, Revital KNIRSH
Life of this patent
Estimating the term…
Abstract
Methods and kits for determining the efficiency of plasma separation from whole blood are provided, using real-time PCR amplification of two amplicons, namely, a short amplicon of e.g. 70-150 bps and a long amplicon of e.g. 350-600 bps. The separation efficiency is determined based on the difference in amplification patterns of the two amplicons.
Claims16
A method for determining the efficiency of plasma separation from whole blood, the method comprising:
- (a) separating plasma from a whole blood sample to provide a plasma sample;
- (b) obtaining DNA from a plasma sample;
- (c) generating by PCR co-amplification:
- (i) a first amplification product of 70-150 bps from a first genomic locus using a first primer pair, and
- (ii) a second amplification product of at least 350 bps from a second genomic locus using a second primer pair;
- (d) calculating a signal intensity for each of said first and second amplification products, wherein said first and second amplification products produce distinct signal intensity differences for plasma DNA and whole blood DNA;
- and
- (e) determining that the plasma sample is separated with acceptable efficiencies when the difference between the signal intensities is above a predefined threshold.
5 more elements
Dependencies are inferred from the claim text.